Cargando…
P70S6 Kinase Phosphorylation: A New Site to Assess Pharmacodynamy of Sirolimus
BACKGROUND: The phosphorylation of p70S6 kinase (p70S6K) represents an important target for sensitive detection on pharmacodynamic effects of sirolimus, but the methods of assessing p70S6K phosphorylation are still unclear. The aim of this study was to investigate p70S6K phosphorylation located down...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834780/ https://www.ncbi.nlm.nih.gov/pubmed/25698201 http://dx.doi.org/10.4103/0366-6999.151670 |
_version_ | 1782427540900544512 |
---|---|
author | Wang, Jun-Yu Fan, Hua |
author_facet | Wang, Jun-Yu Fan, Hua |
author_sort | Wang, Jun-Yu |
collection | PubMed |
description | BACKGROUND: The phosphorylation of p70S6 kinase (p70S6K) represents an important target for sensitive detection on pharmacodynamic effects of sirolimus, but the methods of assessing p70S6K phosphorylation are still unclear. The aim of this study was to investigate p70S6K phosphorylation located down-stream of the mammalian target of rapamycin (mTOR) pathway in peripheral blood mononuclear cells (PBMCs) of liver transplant patients through different methods. METHODS: Seventy-five liver transplant recipients from Beijing Chaoyang Hospital of the Capital Medical University were analyzed in this study. Patients were divided into three groups, patient treated with sirolimus (n = 22), patient treated with tacrolimus (n = 30), patient treated with cyclosporine (n = 23). The p70S6K phosphorylation of PBMCs in patients and healthy control (HC, n = 12) were analyzed by phospho-flow cytometry and Western blotting. A correlation analysis of data from phospho-flow cytometry and Western blotting was performed. Intra-assay variability of p70S6K phosphorylation in HC and different patients were measured. RESULTS: Intra-assay variability of p70S6K phosphorylation in phospho-flow cytometry was from 4.1% to 8.4% and in Western blotting was from 8.2% to 18%. The p70S6K phosphorylation in patients receiving a sirolimus (19.5 ± 7.7) was significantly lower than in HC (50.1 ± 11.3, P < 0.001), tacrolimus (37.7 ± 15.7, P < 0.001) or cyclosporine treated patients (41.7 ± 11.7, P < 0.001). The p70S6K phosphorylation in HC (50.1 ± 11.3) was significantly higher than in tacrolimus (37.7 ± 15.7, P < 0.01) or cyclosporine-treated patients (41.7 ± 11.7, P < 0.01). There was correlation between data from phospho-flow cytometry and data from Western blotting (r = 0.88, P < 0.001). CONCLUSIONS: The degree of mTOR inhibition by assessing p70S6K phosphorylation was established by phospho-flow cytometry and Western blotting. Assessment of p70S6K phosphorylation may play an adjunct role to on pharmacodynamically guide and individualize sirolimus based on immunosuppression. |
format | Online Article Text |
id | pubmed-4834780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-48347802016-04-29 P70S6 Kinase Phosphorylation: A New Site to Assess Pharmacodynamy of Sirolimus Wang, Jun-Yu Fan, Hua Chin Med J (Engl) Original Article BACKGROUND: The phosphorylation of p70S6 kinase (p70S6K) represents an important target for sensitive detection on pharmacodynamic effects of sirolimus, but the methods of assessing p70S6K phosphorylation are still unclear. The aim of this study was to investigate p70S6K phosphorylation located down-stream of the mammalian target of rapamycin (mTOR) pathway in peripheral blood mononuclear cells (PBMCs) of liver transplant patients through different methods. METHODS: Seventy-five liver transplant recipients from Beijing Chaoyang Hospital of the Capital Medical University were analyzed in this study. Patients were divided into three groups, patient treated with sirolimus (n = 22), patient treated with tacrolimus (n = 30), patient treated with cyclosporine (n = 23). The p70S6K phosphorylation of PBMCs in patients and healthy control (HC, n = 12) were analyzed by phospho-flow cytometry and Western blotting. A correlation analysis of data from phospho-flow cytometry and Western blotting was performed. Intra-assay variability of p70S6K phosphorylation in HC and different patients were measured. RESULTS: Intra-assay variability of p70S6K phosphorylation in phospho-flow cytometry was from 4.1% to 8.4% and in Western blotting was from 8.2% to 18%. The p70S6K phosphorylation in patients receiving a sirolimus (19.5 ± 7.7) was significantly lower than in HC (50.1 ± 11.3, P < 0.001), tacrolimus (37.7 ± 15.7, P < 0.001) or cyclosporine treated patients (41.7 ± 11.7, P < 0.001). The p70S6K phosphorylation in HC (50.1 ± 11.3) was significantly higher than in tacrolimus (37.7 ± 15.7, P < 0.01) or cyclosporine-treated patients (41.7 ± 11.7, P < 0.01). There was correlation between data from phospho-flow cytometry and data from Western blotting (r = 0.88, P < 0.001). CONCLUSIONS: The degree of mTOR inhibition by assessing p70S6K phosphorylation was established by phospho-flow cytometry and Western blotting. Assessment of p70S6K phosphorylation may play an adjunct role to on pharmacodynamically guide and individualize sirolimus based on immunosuppression. Medknow Publications & Media Pvt Ltd 2015-03-05 /pmc/articles/PMC4834780/ /pubmed/25698201 http://dx.doi.org/10.4103/0366-6999.151670 Text en Copyright: © 2015 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Wang, Jun-Yu Fan, Hua P70S6 Kinase Phosphorylation: A New Site to Assess Pharmacodynamy of Sirolimus |
title | P70S6 Kinase Phosphorylation: A New Site to Assess Pharmacodynamy of Sirolimus |
title_full | P70S6 Kinase Phosphorylation: A New Site to Assess Pharmacodynamy of Sirolimus |
title_fullStr | P70S6 Kinase Phosphorylation: A New Site to Assess Pharmacodynamy of Sirolimus |
title_full_unstemmed | P70S6 Kinase Phosphorylation: A New Site to Assess Pharmacodynamy of Sirolimus |
title_short | P70S6 Kinase Phosphorylation: A New Site to Assess Pharmacodynamy of Sirolimus |
title_sort | p70s6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834780/ https://www.ncbi.nlm.nih.gov/pubmed/25698201 http://dx.doi.org/10.4103/0366-6999.151670 |
work_keys_str_mv | AT wangjunyu p70s6kinasephosphorylationanewsitetoassesspharmacodynamyofsirolimus AT fanhua p70s6kinasephosphorylationanewsitetoassesspharmacodynamyofsirolimus |